110 filings
Page 3 of 6
CORRESP
1m2u4wutlcz6p7
9 May 22
Correspondence with SEC
12:00am
CORRESP
sp2efufw
6 May 22
Correspondence with SEC
12:00am
UPLOAD
7mf30o0tu5 ogvgwuo
6 May 22
Letter from SEC
12:00am
UPLOAD
h6cdnwvt 8i75q
22 Apr 22
Letter from SEC
12:00am
CORRESP
zmxmn
18 Apr 22
Correspondence with SEC
12:00am
425
lygio09pbehwahg 2t
11 Apr 22
Business combination disclosure
9:21am
8-K
sw2y7upqeb3etcrqch
11 Apr 22
Developing Cutting - Edge Treatments for Debilitating Fibrotic and Neurodegenerative Diseases Corporate Presentation April 2022
8:34am
UPLOAD
ph5urt 5xkm
7 Apr 22
Letter from SEC
12:00am
425
yrdhocqsd
5 Apr 22
Business combination disclosure
9:00am
425
f0f6ez 09bgrxk101u
4 Apr 22
Business combination disclosure
10:55am
S-4/A
61y l9dzck7
1 Apr 22
Registration of securities issued in business combination transactions (amended)
6:45pm
CORRESP
nesyf0vj3dlwdsd01mg
1 Apr 22
Correspondence with SEC
12:00am
425
y1mxnn
30 Mar 22
Business combination disclosure
8:57pm
UPLOAD
hqbxjobr vt7t
25 Mar 22
Letter from SEC
12:00am
425
aao6i 02l
24 Mar 22
Business combination disclosure
4:30pm
425
m20xcs43bqpx9yjk3sr1
15 Mar 22
Business combination disclosure
5:25pm
8-K
ez7nt5flk4xbf
15 Mar 22
Developing Cutting - Edge Treatments for Debilitating Fibrotic and Neurodegenerative Diseases Corporate Presentation March 2022
5:21pm